What diseases does Ceritinib/Ceritinib capsules treat?

Ceritinib is a targeted therapy drug mainly used to treat non-small cell lung cancer (NSCLC). It is an ALK (anaplastic lymphoma kinase) inhibitor that can effectively target and inhibit tumor growth caused by ALK gene mutations. ALK mutations occur more frequently in patients with non-small cell lung cancer, especially in younger patients, patients with no history of smoking, and in certain genotype groups. Ceritinib can effectively prevent the proliferation and spread of tumor cells by selectively inhibiting the activity of ALK protein, thereby delaying the progression of tumors.

Ceritinib was initially approved for the treatment of non-small cell lung cancer that is positive for ALK gene mutations, especially after failure of conventional chemotherapy. For these patients, ceritinib provides an effective treatment option. Compared with traditional chemotherapy, ceritinib has a stronger targeting effect and can reduce damage to normal cells, thereby reducing side effects and improving efficacy.

Clinical studies have shown that ceritinib has a significant effect onALK mutation-positive NSCLC patients, and can prolong progression-free survival (PFS) and improve patients' overall survival (OS). Especially for those who have received chemotherapy, ceritinib can effectively control tumor progression and bring new hope for survival to patients. In addition, ceritinib has also been found to be effective in some patients with brain metastases, able to control brain lesions and reduce related symptoms.

Although ceritinib has achieved significant efficacy in the treatmentALK-positive non-small cell lung cancer, potential side effects still need to be noted when using this drug. The most common side effects include gastrointestinal upset (such as diarrhea, nausea, vomiting), abnormal liver function, and fatigue. To ensure patient safety, regular monitoring of liver function and other related indicators is required when using ceritinib.

Reference materials:https://www.novartis.com/our-products/pipeline/ceritinib